Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki A Morrison

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Late relapses in diffuse large B-cell lymphomaLisa M Baumann Kreuziger, Vicki A Morrison
Leukemia & Lymphoma|April 12, 2013
The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemiaLisa M Baumann Kreuziger, Gobind Tarchand, Vicki A Morrison
Cancer Treatment and Research Communications|October 16, 2021
Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: A review of adherence to present guidelines for usageJeffrey Crawford, Donald C Moore, Vicki A Morrison, et al.
Journal of Geriatric Oncology|November 11, 2019
Chemoimmunotherapy practice patterns in older patients with chronic lymphocytic leukemia: Impact of age and baseline characteristics on treatment choicesAnnie M Jacobsen, David T Gilbertson, Gobind Tarchand, et al.
Journal of Geriatric Oncology|February 22, 2020
Practice patterns in older patients with diffuse large B-cell lymphoma: A medicare analysis, 2007-2015Elizabeth Levin, Yi Peng, Yuanyuan Ji, et al.
Journal of Medical Economics|September 3, 2009
Impact of primary prophylaxis on febrile neutropenia within community practices in the USDawn Hershman, Dana Hurley, Mitchell Wong, et al.
Journal of Geriatric Oncology|August 17, 2019
Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma - Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007-2015Vicki A Morrison, Laurie Hamilton, Augustina Ogbonnaya, et al.
Cancer|September 9, 2005
Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trialAnne H Blaes, Bruce A Peterson, Nancy Bartlett, et al.
Journal of Managed Care Pharmacy : JMCP|May 18, 2007
Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practicesVicki A Morrison, Mitchell Wong, Dawn Hershman, et al.
Journal of Geriatric Oncology|December 11, 2014
Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paperVicki A Morrison, Paul Hamlin, Pierre Soubeyran, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Late relapses in diffuse large B-cell lymphomaLisa M Baumann Kreuziger, Vicki A Morrison
Leukemia & Lymphoma|April 12, 2013
The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemiaLisa M Baumann Kreuziger, Gobind Tarchand, Vicki A Morrison
Cancer Treatment and Research Communications|October 16, 2021
Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: A review of adherence to present guidelines for usageJeffrey Crawford, Donald C Moore, Vicki A Morrison, et al.
Journal of Geriatric Oncology|November 11, 2019
Chemoimmunotherapy practice patterns in older patients with chronic lymphocytic leukemia: Impact of age and baseline characteristics on treatment choicesAnnie M Jacobsen, David T Gilbertson, Gobind Tarchand, et al.
Journal of Geriatric Oncology|February 22, 2020
Practice patterns in older patients with diffuse large B-cell lymphoma: A medicare analysis, 2007-2015Elizabeth Levin, Yi Peng, Yuanyuan Ji, et al.
Journal of Medical Economics|September 3, 2009
Impact of primary prophylaxis on febrile neutropenia within community practices in the USDawn Hershman, Dana Hurley, Mitchell Wong, et al.
Journal of Geriatric Oncology|August 17, 2019
Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma - Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007-2015Vicki A Morrison, Laurie Hamilton, Augustina Ogbonnaya, et al.
Cancer|September 9, 2005
Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trialAnne H Blaes, Bruce A Peterson, Nancy Bartlett, et al.
Journal of Managed Care Pharmacy : JMCP|May 18, 2007
Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practicesVicki A Morrison, Mitchell Wong, Dawn Hershman, et al.
Journal of Geriatric Oncology|December 11, 2014
Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paperVicki A Morrison, Paul Hamlin, Pierre Soubeyran, et al.
Pageof 9